Widya Johannes

953 total citations · 1 hit paper
8 papers, 757 citations indexed

About

Widya Johannes is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cell Biology. According to data from OpenAlex, Widya Johannes has authored 8 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Cell Biology. Recurrent topics in Widya Johannes's work include Fatty Acid Research and Health (2 papers), Phytoestrogen effects and research (2 papers) and Cell death mechanisms and regulation (1 paper). Widya Johannes is often cited by papers focused on Fatty Acid Research and Health (2 papers), Phytoestrogen effects and research (2 papers) and Cell death mechanisms and regulation (1 paper). Widya Johannes collaborates with scholars based in United States, Germany and Netherlands. Widya Johannes's co-authors include Gary J. Miller, Steven K. Nordeen, Adrie van Bokhoven, Heidi L. Miller, Marileila Varella‐Garcia, M. Scott Lucia, Christopher Korch, Tammy E. Hedlund, Lorraine G. Ogden and Mayumi Fujita and has published in prestigious journals such as International Journal of Cancer, Journal of Investigative Dermatology and The Prostate.

In The Last Decade

Widya Johannes

8 papers receiving 739 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular characterization of human prostate carcinoma cell lines

2003 513 citations Adrie van Bokhoven, Marileila Varella‐Garcia et al. The Prostate profile →

Peers

Countries citing papers authored by Widya Johannes

Since Specialization

Citations

This map shows the geographic impact of Widya Johannes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Widya Johannes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Widya Johannes more than expected).

Fields of papers citing papers by Widya Johannes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Widya Johannes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Widya Johannes. The network helps show where Widya Johannes may publish in the future.

Co-authorship network of co-authors of Widya Johannes

This figure shows the co-authorship network connecting the top 25 collaborators of Widya Johannes. A scholar is included among the top collaborators of Widya Johannes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Widya Johannes. Widya Johannes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Heterologous Expression of a Cryptic BGC from Bilophila sp. Provides Access to a Novel Family of Antibacterial Thiazoles 2025 ·ACS Synthetic Biology ·(unknown), (unknown), Martin Larralde, Widya Johannes, Klaus‐Peter Janssen, Georg Zeller, Thorsten Mascher, Tobias A. M. Gulder	1
2	Bacillamide D produced by Bacillus cereus from the mouse intestinal bacterial collection (miBC) is a potent cytotoxin in vitro 2024 ·Communications Biology ·(unknown), (unknown), Widya Johannes, (unknown), Laura M. Carroll, Tianzhe Liu, Daisuke Sasaki, J. F. van den Bosch, Thomas Clavel, Stephan A. Sieber, Georg Zeller, Markus Tschurtschenthaler, Klaus‐Peter Janssen, Tobias A. M. Gulder	2
3	Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial–mesenchymal transition and colorectal cancer aggressiveness 2020 ·International Journal of Cancer ·(unknown), (unknown), Thomas Engleitner, Widya Johannes, Melanie Laschinger, Roland Rad, Ulrich Nitsche, Klaus‐Peter Janssen	16
4	Active N-Ras and B-Raf Inhibit Anoikis by Downregulating Bim Expression in Melanocytic Cells 2008 ·Journal of Investigative Dermatology ·Nathaniel B. Goldstein, Widya Johannes, (unknown), Matthew R. Green, Mayumi Fujita, David A. Norris, Yiqun G. Shellman	20
5	BH3 Mimetic ABT-737 and a Proteasome Inhibitor Synergistically Kill Melanomas through Noxa-Dependent Apoptosis 2008 ·Journal of Investigative Dermatology ·Leslie A. Miller, Nathaniel B. Goldstein, Widya Johannes, Christine Walton, Mayumi Fujita, David A. Norris, Yiqun G. Shellman	50
6	Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro 2005 ·The Prostate ·Tammy E. Hedlund, Adrie van Bokhoven, Widya Johannes, Steven K. Nordeen, Lorraine G. Ogden	49
7	Molecular characterization of human prostate carcinoma cell lines breakdown → 2003 ·The Prostate ·Adrie van Bokhoven, Marileila Varella‐Garcia, Christopher Korch, Widya Johannes, (unknown), Heidi L. Miller, Steven K. Nordeen, Gary J. Miller, M. Scott Lucia	513
8	Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro 2002 ·The Prostate ·Tammy E. Hedlund, Widya Johannes, Gary J. Miller	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact